{"id":"W2147461138","doi":"10.1093/annonc/mdp326","title":"A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada—Clinical Trials Group Trial, MA.12)","year":2009,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Ontario Institute for Cancer Research; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital du Saint-Sacrement; Alberta Cancer Foundation","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Tamoxifen; Epirubicin; Breast cancer; Internal medicine; Oncology; Hazard ratio; Cyclophosphamide; Chemotherapy; Placebo; Fluorouracil; Randomization; Gynecology; Cancer; Randomized controlled trial; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003213088,0.0002633789,0.002602701,0.00009801098,0.00002572052,0.000003935707,0.0001933415,0.0001711777,0.00008256309],"category_scores_gemma":[0.0003626205,0.0001847824,0.0001588067,0.0001252553,0.000260594,0.00001243415,0.00004330639,0.0001100705,9.175375e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001295209,"about_ca_system_score_gemma":0.002184529,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.04362625,"about_ca_topic_score_gemma":0.2484826,"domain_scores_codex":[0.9962479,0.001072936,0.001569962,0.0003999258,0.0003737256,0.0003355085],"domain_scores_gemma":[0.9977349,0.0003340484,0.001164188,0.0002241093,0.0004529127,0.00008983141],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9737913,0.002973192,0.00833132,0.00001659106,0.002802598,0.000009482596,0.0006573178,0.0001471024,0.001379352,0.000009847754,0.0007592665,0.00912263],"study_design_scores_gemma":[0.8237588,0.008325801,0.1659491,0.00005454358,0.0001912159,0.000003008,0.0001561531,0.000005828206,0.0007664211,0.00005396993,0.0005660669,0.0001690429],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933457,0.0008837194,0.000007636002,0.002310119,0.0002403304,0.002747846,0.0002146346,0.000003293293,0.0002466867],"genre_scores_gemma":[0.9960249,0.0009300679,0.0000507286,0.0007324026,0.0002831389,0.001876029,0.00001093483,0.00001531658,0.00007650355],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2048563,"threshold_uncertainty_score":0.9627423,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06129752899936249,"score_gpt":0.40586603943246,"score_spread":0.3445685104330975,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}